LuQi Formula Ameliorates Myocardial Fibrosis by Suppressing TLR4/MyD88/NF- κ B Pathway and NLRP3 Inflammasome Activation in Mice with Myocardial Infarction.
Xiaoqing ZhangHuiyan QuTao YangQian LiuDandan ZhaoWenrui LiuTian WangHua ZhouPublished in: Evidence-based complementary and alternative medicine : eCAM (2022)
B signaling pathway and then inhibited NLRP3 inflammasome activation in MI mice, which indicates potential therapeutic effect of LQF on patients with MI.
Keyphrases